NEW YORK (GenomeWeb News) — Swedish biotech company Genovis said today that Finnzymes will take over US logistical operations and handle some promotions for Genovis products in the US.

Genovis offers RNAi, transfection, imaging, and antibody engineering products to biotechnology companies and academic researchers. Finnzymes develops PCR, quantitative real-time PCR, transposon, and RNA technologies, and it offers PCR instruments, reaction vessels, and DNA polymerases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.